These medications have shown remarkable results in clinical trials: Tirzepatide : According to a 2022 study published in The New England Journal of Medicine, participants who took the maximum dose of Tirzepatide for 72 weeks lost an average of 21 percent of their body weight
Seeing little change in the first month is expected, and it says nothing about how you'll respond once the dose climbs
Those with a personal history of diabetes type I, medullary thyroid cancer, pancreatitis, or eating disorders should not use this medication
Patients who lift weights 23x per week preserve more muscle and have better long-term results
Sudden or severe symptoms, like painless vision loss in one eye, new floaters, or loss of peripheral vision, call for prompt medical attention